Page last updated: 2024-08-21

hematoxylin and Heart Defects, Congenital

hematoxylin has been researched along with Heart Defects, Congenital in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fan, LN; Han, C; Hu, R; Li, J; Li, XJ; Liu, LW; Ma, H; Ta, SJ; Wang, B; Wu, JF; Zhou, MY; Zuo, L1
Channel, S; Eggers, J; Graeter, L; Johnson, P; Latendresse, J; Macmahon, K; Sudberry, G; Warren, A1

Other Studies

2 other study(ies) available for hematoxylin and Heart Defects, Congenital

ArticleYear
[Myocardial biopsy of Liwen procedure: representability and etiological diagnostic value of cardiac samples obtained by a novel technique in patients with hypertrophic cardiomyopathy].
    Zhonghua xin xue guan bing za zhi, 2022, Apr-24, Volume: 50, Issue:4

    Topics: Biopsy; Cardiomegaly; Cardiomyopathy, Hypertrophic; Eosine Yellowish-(YS); Fibrosis; Heart Defects, Congenital; Hematoxylin; Humans; Lipofuscin; Male; Myocardium; Retrospective Studies

2022
Use of hematoxylin stain to enhance evaluation of heart malformations in the fetal rat.
    Teratology, 1999, Volume: 59, Issue:3

    Topics: Animals; Coloring Agents; Dissection; Female; Fetal Heart; Heart Defects, Congenital; Hematoxylin; Pregnancy; Rats; Rats, Sprague-Dawley; Staining and Labeling

1999